Michele Biagioli

17PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyLiquid biopsiesMedical biochemistry - inorganic elements and compoundsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 19, 2026
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.

Michele Biagioli, Cristina Di Giorgio, Silvia Marchianò

|Feb 26, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer.

Cristina Di Giorgio, Nicola Natalizi, Maria Rosaria Sette

|Sep 27, 2025
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders.

Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti

|Apr 25, 2025
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics.

Ginevra Urbani, Elena Rondini, Eleonora Distrutti

|Jan 13, 2025
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4-/- Mice.

Cristina Di Giorgio, Ginevra Urbani, Silvia Marchianò

|Oct 15, 2024
Bile Acids-Based Therapies for Primary Sclerosing Cholangitis: Current Landscape and Future Developments.

Stefano Fiorucci, Ginevra Urbani, Cristina Di Giorgio

Pageof 3

Frequent Collaborators

15 joint publications

Stefano Fiorucci

7 joint publications

Angela Zampella

6 joint publications

Cristina Di Giorgio

5 joint publications

Maria Chiara Monti